Related Experiment Videos
Influence of cholesterol on survival after stroke: retrospective study
A G Dyker1, C J Weir, K R Lees
1University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow.
Insights
Higher serum cholesterol levels are linked to better outcomes and lower mortality after stroke. Further research is needed before cholesterol-lowering guidelines can be applied for stroke prevention.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Cerebrovascular disease, including stroke, is a leading cause of mortality and disability.
- The role of serum cholesterol concentration in stroke outcomes remains an area of active investigation.
- Understanding factors influencing stroke prognosis is crucial for effective secondary prevention strategies.
Purpose of the Study:
- To investigate the association between serum total cholesterol concentration and cerebrovascular disease outcomes.
- To determine if serum cholesterol levels independently predict long-term mortality and short-term outcomes after acute stroke.
Main Methods:
- A retrospective study was conducted involving 977 patients admitted with acute stroke.
- Serum total cholesterol concentration was measured upon admission.
- Stroke type, vascular territory, age, and hyperglycaemia were assessed; outcomes included three-month status and long-term mortality.
Main Results:
- Higher serum cholesterol concentrations were independently associated with reduced long-term mortality after stroke (relative hazard 0.91 per mmol/l increase).
- This association persisted regardless of stroke type, vascular territory, age, or hyperglycaemia.
- Serum cholesterol concentration also independently influenced three-month outcome (P = 0.024).
Conclusions:
- The study suggests an association between poorer stroke outcomes and lower serum cholesterol concentrations.
- Current data do not justify the application of cholesterol-lowering guidelines for secondary stroke prevention in elderly individuals.
- Prospective, controlled studies are required to confirm the potential benefits of cholesterol management in stroke survivors.
Objective:
To investigate the association between serum cholesterol concentration and cerebrovascular disease.
Design:
Retrospective study.
Setting:
Acute stroke unit of inner city general hospital.
Subjects:
977 patients with acute stroke.
Main Outcome Measures:
Serum total cholesterol concentration, type of stroke investigated by computed tomography or magnetic resonance imaging, three month outcome (good (alive at home) or bad (dead or in care)), long term mortality.
Results:
After adjustment for known prognostic factors, higher serum cholesterol concentrations were associated with reduced long term mortality after stroke (relative hazard 0.91 (95% confidence interval 0.84 to 0.98) per mmol/l increase in cholesterol) independently of stroke type, vascular territory and extent, age, and hyperglycaemia. Three month outcome was also influenced independently by serum cholesterol (P = 0.024).
Conclusions:
Our data suggest an association between poor stroke outcome and lower serum cholesterol concentration. Until a prospective controlled study has confirmed the benefits of lowering cholesterol concentration in elderly subjects, the application of cholesterol lowering guidelines cannot be justified as secondary prevention of acute stroke.